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The Placement of Hypomania within the Thought Disorder and Internalizing Spectra of 
Psychopathology 
 Schizotypy refers to traits or symptoms similar to schizophrenia, but in a diminished 
form, and is thought to reflect a liability for schizophrenia-spectrum disorders (Chapman, 
Chapman, Raulin, & Edell, 1978; Meehl, 1962). Like schizophrenia, schizotypy is 
heterogeneous, and can be separated into at least three symptom clusters: positive, negative, and 
disorganized (Kwapil & Barrantes-Vidal, 2015; Raine et al., 1994; Tandon, Nasrallah & 
Keshavan, 2009).  Positive schizotypy refers to subclinical positive symptoms of schizophrenia 
spectrum disorders such as attenuated delusion-like beliefs and hallucinations (Claridge, 1997; 
Lenzenweger, 2006; Meehl, 1962; 1990). Negative schizotypy refers to subclinical negative 
symptoms such as social anhedonia and constricted affect (Lenzenweger & Dworkin, 1996; 
Kwapil, Gross, Silvia, & Barrantes-Vidal, 2013). Disorganized schizotypy includes symptoms, 
like disorganized speech, that reflect difficulties maintaining linear thought processes (Hewitt & 
Claridge, 1989; Kerns & Becker, 2008).  
Another potential risk factor for the development of schizophrenia-spectrum disorders 
and other serious mental illness is hypomania (Eckblad & Chapman, 1986). Hypomania refers to 
elevated mood states similar to mania, but lower in intensity and duration (American Psychiatric 
Association, 2013).  Early work on schizotypy included hypomania among the risk factors for 
schizophrenia (Eckblad & Chapman, 1986).  
Recently, efforts have been made to structurally model psychopathology from a 
dimensional perspective (e.g., Forbush & Watson, 2013; Kotov et al., 2011; Kotov et al., 2017; 
Wright et al., 2012). For example, the recently developed Hierarchical Taxonomy of 
Psychopathology (HiTOP) has six broad spectra including internalizing, disinhibited 
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externalizing, antagonistic externalizing, thought disorder, detachment, and somatoform (Kotov 
et al., 2017). In this model, positive schizotypy traits (i.e., psychoticism) are included on the 
thought disorder spectrum while depression, anxiety, and obsessive compulsive disorder 
symptoms are included on the internalizing spectrum, and negative schizotypy traits (e.g., 
anhedonia, withdrawal, etc.) are included on the detachment spectrum. The somatoform 
spectrum contains disorders of somatization such as illness anxiety disorder, while the 
disinhibited and antagonistic externalizing spectra contains disorders like substance use disorders 
and attention-deficit/hyperactivity disorder (ADHD), respectively. One major unanswered 
question in these taxonomies is to which spectrum/spectra bipolar spectrum disorders belong. 
The HiTOP model provisionally includes mania/hypomania on both the internalizing and 
thought disorder spectra and suggests that more research is needed to understand where it 
belongs in the taxonomy (Kotov et al., 2017). Thus, it is not clear whether hypomania is better 
understood as a facet of internalizing pathology or of a thought disorder.  
One way to help determine the relation that hypomania has with other forms of 
psychopathology is to examine the differential relations that they have with external validators, 
such as personality variables. Maladaptive personality is linked to a wider range of 
psychopathology (Clark, 2005), but the relationship may differ between different personality 
factors and different psychopathology. Thus, it may be helpful to identify underlying personality 
traits that are more likely to be linked to one form of psychopathology over another. As a result 
differing relationships could reveal trends in how hypomania is related to other psychopathology. 
The debate about whether positive schizotypy and hypomania belong on the same spectra 
in structural models mirrors the debate about whether schizophrenia-spectrum disorders can be 
discriminated from bipolar-spectrum disorders (Kotov et al., 2011; Wright et al., 2012). The 
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distinction between schizophrenia and bipolar disorder dates back to Kraepelin, who proposed 
the dichotomy (Kraepelin, 1896). However, it is not clear if this is still an adequate distinction, or 
if a more nuanced model is appropriate. Kraepelin himself later doubted whether these disorders 
could in fact be discriminated (Lake & Hurwitz, 2007; Kraepelin, 1920). Recent molecular 
genetic research has found that schizophrenia-spectrum and bipolar spectrum disorders share 
some genetic susceptibility (Berrettini, 2003; Cardno & Owen 2014; Schulze et al., 2014), and 
behavioral genetic studies have found that schizophrenia-spectrum and bipolar-spectrum co-
aggregate within families (Craddock, O’Donovan, & Owen 2005), suggesting there may not be a 
genetic distinction between the two disorders. Moreover, some studies have proposed a 
transdiagnostic psychotic phenotype consisting of a high number of manic symptoms (Boks, 
Leask, Vermunt, & Kahn, 2007; Kendler et al., 1998; Peralta & Cuesta, 2003). 
 In addition to behavioral and molecular genetic studies, schizophrenia and bipolar show 
similar developmental patterns and risk factors. For instance, both have an average age of onset 
in late adolescence/early adulthood (Lewinsohn, Seeley, Roberts, & Allen, 1997; Sham, 
MacLean, & Kendler, 1994). Both disorders have similar risk factors such as paternal age, 
urbanicity, and childhood adversity such as a loss of parent (Laursen, Munk-Olsen, Nordentoft, 
& Mortensen, 2007). Moreover, both disorders are associated with drug use (Demjaha, 
MacCabe, & Murray, 2011) and both show similar developmental brain structure abnormalities 
(Hallahan et al., 2011).  
Along with a similarity in etiology, schizophrenia and bipolar disorder have similar 
phenomenological characteristics (Murray et al., 2004). The majority of patients with 
schizophrenia experience affective symptoms similar to those in bipolar disorder (Boks, Leask, 
Vermunt, & Kahn, 2007), and studies examining those at high risk for psychosis show that these 
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affective symptoms play an important role in the development of the disorder (Owens & 
Johnstone, 2006). Some theorists have suggested that depression and manic symptoms are 
included in the structure of schizophrenia-spectrum disorders, along with traditional positive, 
negative, and disorganized symptoms (Fonseca-Pedrero et al., 2011; Picardi et al., 2012; Ruggeri 
et al., 2005; Van Der Does et al., 1995). Neurobiological research has revealed that dopamine 
dysregulation is implicated in both disorders (Owen, O’Donovan, & Harrison, 2005), and many 
dopamine-related pharmacological treatments that are beneficial for one disorder tend to be 
helpful for the other. These include most atypical antipsychotics that block dopamine 2 (D2) 
receptors to reduce positive symptoms while simultaneously stabilizing mood symptoms—
primarily mania (Stahl & Grady, 2014). Taken together, these results suggest that schizophrenia 
and bipolar disorder have similar genetic and environmental risk factors, clinical presentations, 
and prognoses.  
 Despite these similarities, there are also important differences observed between 
schizophrenia and bipolar disorder. One of the primary differences between bipolar disorder and 
schizophrenia is the effectiveness of lithium. Lithium has long been the frontline treatment for 
bipolar disorder, with its benefits being more conducive to a primarily manic presentation 
compared to a primarily depressive one (Stahl & Grady, 2014). A recent meta-analysis 
concluded that there is no quality evidence that indicates lithium, on its own, is an efficacious 
treatment for people with psychotic symptoms (Leucht, Helfer, Dold, Kissling, & McGrath, 
2015). This same meta-analysis indicated that there was minimal “low quality” (p. 2) evidence 
that it is even partially effective as an augmenter to antipsychotic medication. This difference in 
treatment response suggests that the disorders may be distinct.  
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In addition to the lack of lithium effectiveness in schizophrenia, other differences 
between bipolar disorder and schizophrenia support the Kraepelinian dichotomy. The LMAN2L 
rs2271893 gene variant is associated with schizophrenia, with conflicting evidence of a 
relationship with bipolar disorder (Chen et al., 2013; Lim et al., 2014). Children eventually 
diagnosed with schizophrenia show more motor, language, and cognition deficits compared to 
their peers who are eventually diagnosed with bipolar disorder, which suggests differences in 
development (Cannon et al., 2002). People with schizophrenia tend to have lower IQ scores than 
people with bipolar disorder (Gilvarry et al., 2000) and more severe executive functioning 
deficits (Qureshi & Frangou, 2002). Thus, there are still key differences between schizophrenia 
and bipolar disorder that suggest they may be distinct disorders.  
As mentioned, the debate regarding the differentiation of positive schizotypy from 
hypomania may show similar patterns to the debate regarding the Kraepelinian dichotomy 
distinguishing schizophrenia and bipolar disorder. Like the latter, positive schizotypy and 
hypomania may have many similarities both in clinical presentations and nomological networks. 
Despite this possibility, few studies have simultaneously examined positive schizotypy and 
hypomania together. The studies that have included both have typically found a moderate 
correlation between measures of hypomania and positive schizotypy (Chapman, Chapman, & 
Raulin 1978; Mahon, Perez-Rodriguez, Gunawardane, & Burdick, 2013; Morvan et al., 2011). 
Moreover, individuals with bipolar disorder show higher levels of positive schizotypy 
(Rybakowski & Klonowska, 2011). There is evidence that people experiencing high levels of 
psychological distress are prone to both positive schizotypy and hypomania (Preti et al., 2015) as 
well as a common relationship with non-pathological personality characteristics such as artistic 
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creativity (Rawlings & Locarnini, 2008). Thus, more research is needed to examine whether and 
how schizotypy and hypomania are related. 
In contrast to evidence showing that positive schizotypy and hypomania are similar, other 
research suggests differences between the constructs. Although people with bipolar disorder 
score higher on measures of schizotypy compared to healthy controls, they still score 
significantly lower than people with schizophrenia (Rossi & Daneluzzo, 2002). This may 
indicate that, although similar, there are different liabilities wherein schizotypy represents an 
increased liability for schizophrenia, while hypomania represents more of an increased liability 
for bipolar disorder.  
One direct way for determining whether constructs can be discriminated from each other 
is confirmatory factor analysis (Rubio, Berg-Weger & Tebb, 2001). However, to my knowledge, 
only one study has measured both schizotypy and mania in a confirmatory factor analysis. This 
study found that positive schizotypy, negative schizotypy, and mania loaded on to separate 
factors, but shared a single general factor (Preti et al., 2015). It is important to note, however, 
that this study used only a single measure of mania and single measure of schizotypy. Thus, 
these results may represent the separation of those measures rather than differences in the latent 
constructs. In addition, multiple other studies using exploratory factor analyses have found that a 
two-factor structure, separating hypomania and positive schizotypy (Preti et al., 2015), and 
hypomania and negative schizotypy (Akiyama et al., 2005) fits the data better than a single-
factor structure. 
 There has been previous work suggests that hypomania may be more related to 
internalizing psychopathology than psychosis. Most notably, hypomania and the presence of a 
major depressive episode are both included as criteria for bipolar II disorder in the DSM-5. 
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Empirically, past research has shown that depression is associated, though not very strongly, 
with hypomania (Meyer, 2002). In fact, the coexistence of these two symptom sets has been seen 
in community longitudinal research. Patients with major depressive disorder and those with 
primarily hypomanic symptoms of bipolar disorder tend to show similar patterns in the future 
development of additional mood and anxiety disorders and the utilization of mental health 
resources (Päären et al., 2014). A qualitative analysis of interviews conducted with bipolar II 
disorder patients showed a common theme that many patients were aware of hypomania usually 
leading to depression (Fletcher, Parker, & Manicavasagar, 2013). However, hypomania and 
depression are in some ways diametrically opposed constructs since depression is primarily a 
negative affective state while hypomania is, typically, primarily a positive affective state. 
 One major difference between depression and mania (or hypomania) is the response to 
certain treatments. Lithium, as mentioned before, is effective in treating symptoms of bipolar 
disorder, but it is not as effective at reducing unipolar depressive symptoms. Selective serotonin 
reuptake inhibitors (SSRIs) are rarely given to bipolar disorder patients for fear that the 
alleviation of a depressive episode may lead to a manic/hypomanic state (Stahl & Grady, 2014). 
The difference between depression and hypomania has also been shown empirically. Patients 
who have previously only experienced a hypomanic state show different manic symptom 
patterns than those who have experienced both a hypomanic state and a depressed state (Benazzi 
& Akiskal, 2003), reflecting the differences between depression and hypomania 
Similar to hypomania, positive schizotypy is also associated with depression. It is well-
known that many people with frank psychosis have experienced a depressive episode at some 
point (Martin, Cloninger, Guze, & Clayton, 1985). This co-occurrence also exists, but to a lesser 
extent, for depression and positive schizotypy. One may hypothesize that depression would be 
  
 8 
more strongly related to negative schizotypy due to the overlap of anhedonia in negative 
schizotypy, but previous research has shown that depression is more strongly associated with 
positive than negative schizotypy (Emsley et al., 1999; Drake et al., 2004; Lysaker, Bell, Bioty, 
& Zito, 1995). When tested empirically, negative affect was moderately associated with positive 
schizotypy, furthering the support for this relationship even at a subclinical level. 
A second symptom commonly considered as part of internalizing pathology is anxiety. 
Although the evidence linking hypomania and generalized anxiety is relatively sparse, the 
comorbidity rate of generalized anxiety disorder and bipolar disorder is more established. Some 
estimates show that roughly one in five people with bipolar I disorder experiences generalized 
anxiety at some point (Simon et al., 2004), though bipolar I disorder showed a higher rate than 
bipolar II disorder, for which hypomania is a key feature. Other estimates are as high 30%-40% 
for generalized anxiety disorder and significantly higher when including other anxiety disorders 
(Boylan et al., 2004; Pini et al., 1999). This is considerably higher than the rates of anxiety 
disorders in people without bipolar disorder. One study examining the link between hypomania 
and generalized anxiety reported that young adults rate higher levels of anxiety during a time 
period the authors refer to as “dark hypomania,” (primarily irritable and risk taking) though 
importantly not during “bright hypomania” (primarily active with elevated mood; Brand et al., 
2015, p. 25). Finally, some symptom components (e.g., hyperarousal), are important 
characteristics of both anxiety and hypomania. This potentially indicates that the association 
between hypomania and generalized anxiety involves multiple other factors. 
In addition to generalized anxiety, social anxiety is also considered to be a part of the 
internalizing spectrum. Although less researched than the relations among anxiety, depression, 
and mania, some research suggests that there may be a subset of people with social anxiety who, 
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when on medication, show hypomanic symptoms (Valença et al., 2005). These patients exhibit 
similar clinical features to patients with bipolar II disorder. Some debate that this is not actually a 
comorbidity, but instead a subtype of bipolar disorder where social anxiety is the primary 
symptom (Himmelhoch, 1998). In this perspective, only when removing the presence of anxious 
symptoms are clinicians and scores on psychological tests able to capture the presence of 
hypomania (i.e., the patients were always hypomanic, but social anxiety masked the symptoms). 
Others argue that social anxiety may precede hypomania, but very few people exhibit social 
anxiety symptoms during hypomanic episodes (Perugi et al., 2001). Regardless of what the 
relationship may be, previous studies have been retrospective and used mainly descriptive 
statistics. This is to say that an empirical rigorous test of the connection between social anxiety 
and hypomania is still needed, but that there is evidence that a significant association exists. 
In contrast to hypomania, a long line of research suggests that schizotypy is related to 
social anxiety (Brown, Silvia, Myin-Germeys, Lewandowski, & Kwapil, 2008; Pallanti, 
Quercioli, & Hollander, 2004; Raine, Lencz, & Mednick, 1995). Early conceptualizations of 
schizotypy included social anxiety as a sign of schizotypy (Meehl, 1962; 1990). This is reflected 
in that excessive social anxiety is a symptom of schizoptypal personality disorder in the DSM-5 
(American Psychiatric Association, 2013). The exact relations between social anxiety and 
schizotypy are unclear. Some research suggests that it may be similar to, but distinct from, social 
anhedonia, which is a prominent negative schizotypy symptom (Cicero et al., 2015). In contrast, 
social anxiety may be more closely related to the “affective instability” often seen in positive 
schizotypy (Brown et al., 2008, p. 131). This difference was seen in a comparison of social 
anxiety and social anhedonia. Those with social anxiety were higher in positive schizotypy while 
those with social anhedonia were higher in negative schizotypy (Brown, Silvia, Myin-Germeys, 
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& Kwapil, 2008). In a follow-up study, social anxiety was associated with positive schizotypy 
(Brown et al., 2008). Thus, I expected to find that positive schizotypy, but not hypomania, would 
be positively correlated with social anxiety.  
As mentioned, negative affect—including anxiety and depression—is associated with 
positive schizotypy, and past research has shown that this association is stronger for positive 
schizotypy than negative schizotypy  (Lewandowski et al., 2006). Negative affect is also 
considered to be one of the emerging symptoms when psychotic symptoms are first developing 
(Ulloa et al., 2000), and could potentially be related to the persistence of these initial positive 
symptoms (Debbané, Van der Linden, Gex-Fabry, & Eliez, 2009; Escher, Romme, Buiks, 
Delespaul, & Van Os, 2002). Despite this evidence, the association appears to be moderate at 
best.  
Another disorder associated with internalizing pathology that is related to both bipolar 
disorder and psychotic spectrum disorders is obsessive-compulsive disorder (OCD). Multiple 
studies have shown that OCD and bipolar disorders are often comorbid, with estimates as high as 
35% of patients with bipolar disorder also meeting criteria for OCD (e.g., Angst, 1998; Kruger et 
al., 1995; Perugi et al., 2001; see Amerio, Odone, Liapis, & Ghaemi, 2014 for a meta-analysis). 
Due to this high comorbidity, psychopathologists have suggested that there may be a subtype of 
OCD that includes mania (Hantouche et al., 2003). Those with comorbid bipolar disorder and 
OCD have significantly more functional impairments and more hospitalizations compared to 
those with only OCD alone (Zutshi, Kamath, & Reddy, 2007). Thus, one would expect to find 
that hypomania would be positively correlated with OCD symptoms.  
Similar to the association between hypomania and OCD, positive schizotypy and OCD 
often co-occur (Poyurovsky & Koran, 2005) and the two are highly related (Chmielewski & 
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Watson, 2008). In a study of adults with OCD, half had at least mild schizotypal symptoms with 
about a quarter being moderate or higher (Sobin et al., 2000). This could be interpreted, similar 
to the hypomanic association, as a subtype of OCD patients who experience clinically relevant 
psychotic symptoms. For those high in schizotypy, positive psychotic symptoms seem to cluster 
with OCD symptoms more strongly than at lower levels of schizotypy, potentially supporting an 
OCD subtype of positive schizotypy (Suhr, Spitznagel, & Gunstad, 2006). OCD symptoms are 
also common in people with schizophrenia, with estimates suggesting that as many as 60% of 
people with schizophrenia have OCD symptoms (Berman et al., 1998). This is intuitive from a 
phenomenological perspective, since schizotypal symptoms such as irrational beliefs can be very 
similar to the types of irrational beliefs about danger seen in those with OCD. This may be due to 
similar neurobiological pathways in both disorders (Tibbo & Warneke, 1999). Although 
obsessions must be recognized as irrational to be considered on the OCD-spectrum, people with 
subclinical delusion-like beliefs also have insight that their beliefs may not be true. Like 
hypomania, I expected to find that positive schizotypy would be positively correlated with 
obsessive-compulsive disorder symptoms. 
An important point to note regarding the association of hypomania within other forms of 
mental illness is the possible connection between hypomania and externalizing psychopathology. 
Specifically, research has demonstrated the possibility that ADHD and (hypo)mania are 
associated. One argument supporting this perspective is that people who go on to develop bipolar 
disorder are often first diagnosed with ADHD in childhood (Biederman et al., 1998; Carlson, 
1998; Geller et al., 1998). This may represent a high misdiagnosis rate or a high comorbidity, but 
either way indicates that the two are clinically similar. Despite this, research supporting the 
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perspective of hypomania being externalizing is relatively unconvincing. Therefore, the current 
study will focus more on hypomania’s associations with internalizing and thought disorders.   
As mentioned previously, efforts have been made to structure psychopathology in a way 
consistent with the emerging dimensional approach to mental illness. Perhaps the leading set of 
studies in this new approach is Hierarchical Taxonomy of Psychopathology (HiTOP). This group 
has already published a preliminary analysis compiling research on the six spectra mentioned 
above (Kotov et al., 2017), and currently has several other projects in preparation. The goal of 
HiTOP is to solve the issues inherent in the current classification system of psychopathology as 
definable categories. The empirical approach taken in efforts like this is important to better 
classify different psychopathologies while simultaneously acknowledging the similarities and co-
occurrences (Kotov et al., 2017).  
One important aspect of HiTOP’s first publication (Kotov et al., 2017) is the placement 
of mania within the six spectra. Although other disorders and their symptoms, such as substance 
use or schizophrenia, are clearly understood to belong to a particular spectrum, mania’s position 
is still considered ambiguous. Evidence exists indicating that mania, and a corresponding 
diagnosis of a bipolar disorder, is associated with other internalizing disorders (Blanco et al., 
2015; Forbush & Watson, 2013; Keyes et al., 2013; Kotov et al., 2015; Watson, 2005; Watson et 
al., 2012). This evidence is not comprehensive, however, as other research has pointed to mania 
existing within the thought disorder spectrum that includes schizophrenia and other psychotic 
disorders (Caspi et al., 2014; Keyes et al., 2013; Kotov et al., 2011). In this line of research, the 
similarities between mania and the positive symptoms of schizophrenia indicate overlapping 
features. The HiTOP model acknowledges that crossloading is possible, and potentially even 
expected when examining “such interstitial constructs” (Kotov et al., 2017, p. 463). 
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Interestingly, despite much research examining mania and how it fits into the larger 
structure of psychopathology, there has been relatively little research examining hypomania’s 
position in that same structure. HiTOP acknowledges bipolar I and II together as a 
syndrome/disorder associated with the subfactor mania, though research does not appear to 
directly examine hypomania to determine if it in fact shares common characteristics with both 
internalizing and thought disorder (as mania does). It is important to know this, however, as the 
integration of differing levels of severity into a comprehensive model of psychopathology is 
necessary to ensure that the model can be applied in a variety of contexts and situations. 
OCD is another example of an interstitial construct similar to mania. Within the HiTOP 
model, OCD is thought of as a subset of the fear cluster within internalizing disorders. Despite a 
long line of research supporting OCD as an internalizing disorder (e.g., Keyes et al., 2013; 
Krueger & Markon, 2006; Miller et al., 2008), there is some evidence that OCD shares common 
features with subfactors of the thought disorder spectrum (Caspi et al., 2014; Chmielewski & 
Watson, 2008). Moreover, OCD could function similarly to mania in that it shares common 
features of multiple spectra rather than fitting neatly into one dimension. 
In addition to the structural relations of different psychopathologies, the association 
between psychopathology and normal personality traits is also important to examine. 
Specifically, the five-factor model of personality, including extraversion, agreeableness, 
conscientiousness, neuroticism, and openness (e.g., Costa & McCrae, 1992; Goldberg, 1993), 
shows important relations with different forms of psychopathology. 
Maladaptive personality is linked with psychopathology (Clark, 2005). In fact, the five-
factor model of personality has been linked to virtually every psychopathology from anxiety and 
depression (Kotov, Gamez, Schmidt, & Watson, 2010) to schizophrenia and other severe mental 
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illness (Schroeder, Naber, & Huber, 2014) to personality disorders (Samuel & Widiger, 2008; 
Saulsman & Page, 2004). This research consistently finds that extraversion, agreeableness, and 
conscientiousness are all negatively associated with psychopathology (i.e., as these traits 
increase, psychopathology decreases) while neuroticism is positively associated with 
psychopathology (Clark, 2005; Kotov et al., 2010, Saulsman & Page, 2004). Perhaps the 
strongest connection is between anxiety and neuroticism, as neuroticism is essentially the trait 
version of the anxiety state. Openness is not generally considered to be as relevant in many of the 
associations between personality factors and psychopathology (Kotov et al., 2010, Samuel & 
Widiger, 2008; van der Heijden et al., 2013, Watson, Clark, & Chmielewski, 2008). This could 
represent a flaw in measurement of openness (e.g., that it does not capture pathological 
openness) or a differential way that openness affects experiences compared to other personality 
factors. The current research aims to replicate these findings as a way to validate this structural 
model of psychopathology.  
Current Study 
The primary goal of the current research was to examine where hypomania fits within 
structural models including positive schizotypy, negative schizotypy, depression, anxiety, social 
anxiety, and obsessive-compulsive disorder. Based on previous research, the main tests 
examined comparisons between models that allowed hypomania to be associated with positive 
schizotypy, depression, both, or neither. Due to discrepancies in the literature surrounding OCD, 
a similar set of comparisons were conducted, and combined with comparisons that included 
hypomania in different classifications. A secondary goal was to examine how personality factors 
differential relate to different forms of psychopathology, in order to externally validate the 
placement of hypomania within the structural model. 
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Method 
Participants  
Participants were 949 (Mage = 20.48, SD = 3.98) undergraduates from a large, public 
university. They participated in exchange for partial class credit. The sample was ethnically 
diverse, with 40.6% Asian, 17.3% White, 3.1% Hispanic, 1.6% Pacific Islander, 1.3% Black, 
27.7% Multiethnic, and 8.3% Other. The sample was a majority female (74.3%). Originally, 
there were 1104 participants, but 155 were excluded for scoring above five on a scale for 
infrequent responding. This scale contains items that are highly unlikely to be endorsed such, “I 
have never spoken to a person wearing eye glasses.” Higher scores indicate a higher likelihood 
of careless responding. 
Materials 
Positive Schizotypy. The first measure of positive schizotypy was the Magical Ideation 
Scale (MagicId; Eckblad & Chapman, 1983). The MagicId is a 30-item, true-false measure that 
assesses unrealistic beliefs of causality (e.g., “The hand motions that strangers make seem to 
influence me at times”). The second measure of positive schizotypy was the Perceptual 
Aberration Scale (PerAb; Chapman, Edell, & Chapman, 1980). The PerAb is a 35-item, true-
false scale designed to measure psychotic-like distortions such as, “I have sometimes felt that 
some part of my body no longer belongs to me.” Both the MagicId and the PerAb have notable 
support for their reliability and validity (Edell, 1995). In the current sample, the MagicId and 
PerAb had Cronbach’s α’s of .82 and .90, respectively.  The third and fourth measures of 
positive schizotypy were the Unusual Perceptual Experiences (SPQ-UPE) and the Magical 
Ideation (SPQ-MI) subscales of the Schizotypal Personality Questionnaire (SPQ; Raine, 1991). 
The SPQ-UPE contains 9 items measuring abnormal sensations (e.g., “I often hear a voice 
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speaking my thoughts aloud”) and had a Cronbach’s α = .77 in the current study. The SPQ-MI 
comprises 7 items assessing odd beliefs (e.g., “Are you sometimes sure that other people can tell 
what you are thinking”) and had a Cronbach’s α = .75 in the current study. The SPQ is one of the 
most widely-used measures of schizotypy and has shown good factor structure and validity (e.g., 
Cicero, 2015; Compton Goulding, Bakeman, & McClure-Tone, 2009; Fonseca-Pedrero, et al., 
2014; Fossati et al., 2003)   
Negative Schizotypy. The first measure of negative schizotypy was the Social Anhedonia 
scale (SocAn; Chapman et al., 1976). This measure contains 40 true-false items that assess a 
general lack of pleasure and enjoyment from social interactions (e.g. “I am usually content just to 
sit alone, thinking and daydreaming”). The Social Anhedonia scale predicts future development 
of psychosis (e.g., Gooding, Tallent, & Matts, 2005) and showed good reliability in the current 
sample (α = .82). 
 Second and third measures of negative schizotypy were the Constricted Affect and No 
Close Friends subscales of the SPQ (Raine, 1991). The Constricted Affect scale is comprised of 
8 items assessing a lack of emotional range (e.g., “I rarely laugh or smile). The No Close Friends 
subscale is 9 items and measures a lack of closeness in relationships (e.g., “I attach little 
importance to having close friends”). These scales have been shown to load strongly onto a 
negative schizotypy latent factor (e.g., Cicero, 2015, Preti et al., 2015), and are highly associated 
with SCID ratings of negative symptoms (Raine, 1991). In the current study the Constricted 
Affect and No Close Friends subscales had Cronbach’s α = .78 & .81, respectively. 
Hypomania. The first measure of hypomania was the Hypomanic Personality Scale (HPS; 
Eckblad & Chapman, 1986). The HPS is a 48-item true/false questionnaire used to identify 
persons with hypomanic personality traits (Eckblad & Chapman, 1986). An example of a true-
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keyed item is, “Sometimes ideas and insights come to me so fast that I cannot express them all.” 
Studies have shown the HPS to have good cross-cultural equivalency (Meyer, 2002). In this 
sample the HPS had a Cronbach’s α = .91. The second measure of hypomania was the 
Cyclothymia subscale of the Temperament Evaluation of Memphis, Pisa, Paris, and San Diego 
Autoquestionnaire (TEMPS-A; Akiskal et al., 2005). The Cyclothymia factor of the TEMPS-A 
contains 12 items with statements such as, “The way I see things is sometimes vivid, but at other 
times lifeless.” This subscale showed excellent internal consistency (Cronbach’s α = .91; Akiskal 
et al., 2005) in past studies and good reliability in the current sample (Cronbach’s α = .87). A 
third measure of hypomania was the Mood Disorder Questionnaire (MDQ; Hirschfeld et al., 
2000), which is a 13-item, yes/no measure that can be used as a screener for bipolar disorders 
(Hirschfeld et al., 2000). With a cutoff score of 7, the MDQ has good sensitivity and very good 
specificity (Hirschfeld et al., 2000). The scale has items that examine energy level (e.g., “Has 
there ever been a period of time when… you were not your usual self and you were much more 
talkative or spoke faster than usual?”), mood (e.g., “…you felt much more self-confident than 
usual), and irritability (e.g., “…you were so irritable that you shouted at people or started fights 
or arguments?). In the current study, the MDQ had a Cronbach’s α = .85. 
Depression. The first measure of Depression was the Center for Epidemiological Studies- 
Depression Questionnaire (CES-D; Radloff, 1977). The CES-D is a 20-item scale that measures 
common symptoms of depression such as sleep disturbances and eating habits. Participants rate 
each item on a scale from 0 (Rarely or none of the time) to 3 (Most or all of the time). The CES-
D is primarily used to screen for current episodes of depression or assess levels of depressive 
symptoms (Waugh, Meyer, Youngstrom, & Scott, 2014). In the current sample, the CES-D had a 
Cronbach’s α = .96. A second measure of depression was the Depression Subscale of the 
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Depression Anxiety Stress Scale (DASS-Depression; Lovibond & Lovibond, 1993). The DASS 
is a 42-item self-report questionnaire for which participants rate statements from 0 (did not apply 
to me at all) to 3 (applied to me very much, or most of the time; Lovibond & Lovibond, 1993). 
Each of the three subscales of the DASS contains 14 items. Multiple studies have found support 
for excellent internal consistency of the Depression subscale (Lovibond & Lovibond, 1993; 
Lovibond & Lovibond, 1995; Antony, Bieling, Cox, Enns, & Swinson, 1998). Items address 
common symptoms of depression such as, “I felt that life wasn’t worthwhile.” In the current 
study, the depression subscale of the DASS showed excellent internal consistency (α = .93). 
 A third measure of depression was the Inventory of Depression and Anxiety Symptoms 
(IDAS) General Depression Scale. The IDAS is a 64-item measure, 20 of which make up the 
General Depression scale (Watson et al., 2007). Participants rate statements on a scale from 1 
(not at all) to 5 (extremely) regarding how much the statement applied to them over the past two 
weeks. The General Depression scale showed excellent reliability (Cronbach’s α = .92) in the 
current study and correlates well with other measures of depression (Watson et al., 2007). A 
fourth measure of depression was the Physical Health Questionnaire-9 (PHQ-9; Kroenke, 
Spitzer, & Williams, 2001). The PHQ-9 is a 9-item checklist used to screen for depression or 
evaluate depressive symptoms. Participants rate how often they have felt a certain symptom over 
the past two weeks from 0 (not at all) to 3 (nearly every day). Items address common symptoms 
such as lack of interest, feeling down, sleep disturbances, and changes in appetite. The scale has 
good test-retest reliability (Kroenke, Spitzer, & Williams, 2001), and showed excellent internal 
consistency in the current sample (α = .90). 
 Finally, a fifth measure of depression was the Patient Reported Outcomes Measurement 
Information System-Depression (PROMIS-B). The PROMIS is a measure developed by the 
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National Institute of Health (NIH) that utilized item response theory to create a pool of questions 
measuring patient-reported outcomes across a variety of domains, with research finding that the 
scales show strong reliability and validity (see Cella et al., 2010 for a summary). Specifically, the 
depression scale of the PROMIS measures negative mood, decreased positive affect, information 
processing deficits, negative views of the self, and negative social cognition. In the current study, 
the depression scale had a Cronbach’s α = .96. 
Anxiety. The first measure of anxiety was the Anxiety subscale of the Depression Anxiety 
Stress Scale (DASS; Lovibond & Lovibond, 1993). The DASS Anxiety subscale contains 14 
items typically experienced during anxiety (e.g., “I felt scared without any good reason). 
Participants rate items on a Likert scale from 0 to 3, in terms of how much that statement applies 
to them. The anxiety subscale is highly correlated with the Beck Anxiety Inventory (Lovibond & 
Lovibond, 1995) and showed good reliability in the current study (α = .89).  
A second measure of Anxiety was the Patient Reported Outcomes Measurement 
Information System-Anxiety (PROMIS-A). As mentioned before, the PROMIS is a large-scale 
measure designed by the NIH to measure a variety of health related domains. The anxiety scale 
includes items assessing fear, anxious misery, hyperarousal, and somatic symptoms related to 
arousal (Cella et al., 2010). In the current study, this scale showed excellent reliability (α = .95). 
A third measure of anxiety was the Penn State Worry Questionnaire (PSWQ; Meyer, 
Miller, Metzger, & Borkovec, 1990). The PSWQ is a 16-item Likert scale for which participants 
rate from 0 (never) to 6 (almost always) how much an item applies to them. The scale is 
designed to measure pervasive worry (e.g., “I am always worrying about something”) as an 
independent trait. The PSWQ has high internal consistency and test-retest reliability (Meyer et 
al., 1990). In the current study, the PSWQ had a Cronbach’s α = .92. 
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Social Anxiety. The first measure of social anxiety was the Social Anxiety subscale of the 
IDAS (Watson et al., 2007). The Social Anxiety subscale of the IDAS contains five items that 
are traditionally experienced during anxiety such as, “I was worried about embarrassing myself 
socially.” The scale has good reliability across a wide range of populations and correlates with 
other measures of social anxiety (Watson et al., 2007). In the current sample, the IDAS showed 
good reliability (α = .87). A second measure of social anxiety was the Excessive Social Anxiety 
subscale of the SPQ (SPQ-ESA; Raine, 1991). SPQ-ESA is an 8-item subscale that evaluates 
anxiety in situations involving interaction with others (e.g., “I feel very uncomfortable in social 
situations involving unfamiliar people”). The ESA subscale had good reliability in the current 
study (α = .86). 
Obsessive-Compulsive Disorder. The first measure of obsessive-compulsive disorder 
symptoms was the Obsessive Compulsive Inventory-Revised (OCI-R; Foa et al., 2002). The 
OCI-R is an 18-item questionnaire designed to measure distress from OCD symptoms. 
Participants rate the severity of symptoms (e.g., “I need things to be arranged in a certain way) 
over the past month on a scale from 0 (not at all) to 4 (extremely). Both the total score and 
subscale scores have good internal consistency in clinical samples (Foa et al., 2002), but only the 
total scale shows adequate test-retest reliability for an undergraduate sample (Hajcak, Huppert, 
Simons, & Foa, 2004). Another study found that the OCI-R was correlated with other measures 
of OCD, while also discriminating from other anxiety disorders (Abramowitz & Deacon, 2006). 
In the current sample, the OCI-R had excellent internal consistency (α = .95). A second measure 
of OCD symptoms was the Vancouver Obsessional Compulsive Inventory (VOCI; Thordarson et 
al., 2004). The VOCI is a 55-item measure aimed at assessing a variety of obsessions, 
compulsions, and other characteristics of OCD (e.g. “I am excessively concerned about getting 
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germs and disease”). Items are rated on a 5-point scale from “not at all” to “very much” 
regarding how true the statement is. The VOCI total score has very good internal consistency and 
excellent test-retest reliability (Thordarson et al., 2004). In this sample, the VOCI had a 
Cronbach’s α = .94. 
Big Five Personality. Personality was measured using Goldberg’s (1992) Big-Five Factor 
Markers from the International Personality Item Pool (Goldberg et al., 2006). This measure is 
correlated with other measures of the Big-Five and has a wide research base supporting its 
validity (e.g., Briley, Domiteaux, & Tucker-Drob, 2014; Gnambs, 2014; Gow, Whiteman, Pattie, 
& Deary, 2005; Saucier & Goldberg, 2002; Zheng et al., 2008). The five factors and their 
reliabilities in the current study are as follows: Extraversion α = .89, Agreeableness α = .89, 
Conscientiousness α = .82, Neuroticism α = .90, Openness α = .84. 
Procedure 
Participants completed the study online in a single session taking an average of 60 
minutes with the online program Qualtrics. Participants completed the study in the following 
order: Center for Epidemiological Studies Depression Scale Revised, Inventory of Depression 
and Anxiety Symptoms, Obsessive Compulsive Inventory- Revised, the Patient Health 
Questionnaire-9, Patient Reported Outcomes Measurement Information System- Anxiety Scale, 
Patient Reported Outcomes Measurement Information System- Depression Scale, The 
Schizotypal Personality Questionnaire, The Survey of Attitudes and Experiences (including the 
Perceptual Aberration Scale, Magical Ideation Scale, and Social Anhedonia Scale), The 
Temperament Evaluation of the Memphis, Pisa, Paris, and San Diego-autoquestionnaire, The 
Mood Disorder Questionnaire, the Vancouver Obsessional Compulsive Inventory, the Penn State 
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Worry Questionnaire, The Hypomanic Personality Scale, and the International Personality Item 
Pool. 
Data Analyses. All models were tested with M-Plus Version 7.4 (Muthen & Muthen, 
1998-2016). Data were extracted with Maximum Likelihood parameter estimates (ML). The 
primary comparison of model fit was Bayesian Information Criterion (BIC), as recommended by 
current literature (Vrieze, 2012). In addition to BIC, Sample-Size Adjusted BIC (SABIC) and 
Akaike Information Criterion (AIC) were used to evaluate comparative fit (i.e., one model 
against another). Root Mean Squared Error of Approximation (RMSEA), Comparative Fit Index 
(CFI), Tucker-Lewis Index (TLI), and Standardized Root Mean Squared Residual (SRMSR) 
were used to evaluate absolute fit. Following previous work, the models were considered 
acceptable if (a) CFI and TLI > .90, and (b) RMSEA and SRMSR < .10. Model fit was 
considered excellent if (a) CFI and TLI > .95, and (b) RMSEA and SRMSR < .05. For all 
analyses, I allowed the errors of subscales from the same measure to correlate with each other. 
 Thirteen models were tested to determine the best fitting model. (1) A seven-factor model 
with positive schizotypy, negative schizoytypy, hypomania, depression, anxiety, social anxiety, 
and OCD loading on separate factors. This model tested whether hypomania, positive 
schizotypy, and OCD were distinct constructs that are not part of common higher order factors. 
(2) A six-factor model with hypomania scales and positive schizotypy scales loading onto the 
same factor. This model examined whether hypomania could be discriminated from positive 
schizotypy (i.e., if this model fit better than model 1, I would conclude that hypomania could not 
be discriminated from positive schizotypy). (3) A six-factor model with hypomania scales and 
depression scales loading onto the same factor. This model examined whether hypomania could 
be discriminated from depression. (4) A six-factor model with hypomania scales loading onto 
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both the positive schizotypy scale and the depression scale. This model tested whether 
hypomania is a part of both positive schizotypy and depression. (5) A seven-factor model with 
two higher-order factors, thought disorder (positive schizotypy and hypomania) and internalizing 
(depression, anxiety, social anxiety, OCD, and hypomania). This model tested whether 
hypomania best fits as being part of both a higher order thought disorder spectrum and a higher-
order internalizing spectrum. (6) A seven-factor model with two higher-order factors, thought 
disorder (positive schizotypy, negative schizotypy, and hypomania) and internalizing 
(depression, anxiety, social anxiety, OCD, and hypomania). This model examined whether 
hypomania should be a part of both higher order factors while also including negative schizotypy 
as a thought disorder component. (7) A seven-factor model with two higher-order factors, 
thought disorder (positive schizotypy, hypomania, and OCD) and internalizing (depression, 
anxiety, social anxiety, OCD, and hypomania). This model tested whether both OCD and 
hypomania can be considered part of a higher order thought disorder spectrum and higher order 
internalizing spectrum. (8) A seven-factor model with two higher-order factors, thought disorder 
(positive schizotypy, negative schizotypy, hypomania, and OCD) and internalizing (depression, 
anxiety, social anxiety, OCD, and hypomania). This model tested the same possibility as model 
8, but with negative schizotypy as a part of thought disorder. (9) A seven-factor model with two 
higher-order factors, thought disorder (positive schizotypy and hypomania) and internalizing 
(depression, anxiety, social anxiety, and OCD). This model examined if hypomania should solely 
be included as part of thought disorder with OCD exclusively part of internalizing. (10) A seven-
factor model with one higher-order factor, internalizing (depression, anxiety, social anxiety, 
OCD, and hypomania). This model examined hypomania as only being a component of a higher-
order internalizing spectrum, thereby eliminating the higher order thought disorder component. 
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(11) A seven-factor model with two higher-order factors, thought disorder (positive schizotypy 
and negative schizotypy) and internalizing (depression, anxiety, social anxiety, OCD, and 
hypomania). This model tested the possibility of hypomania exclusively loading on internalizing 
while positive and negative schizotypy encompass the thought disorder spectrum. (12) A seven-
factor model with two higher-order factors, thought disorder (positive schizotypy and OCD) and 
internalizing (depression, anxiety, social anxiety, and OCD). This model examined if hypomania 
forms its own factor entirely without being part of a higher order factor. OCD was examined as a 
part of both thought disorder and internalizing. (13) A seven-factor model with one higher-order 
factor, internalizing (depression, anxiety, and social anxiety). In this model, OCD and 
hypomania were both considered independent, leaving positive schizotypy, negative schizotypy, 
OCD and hypomania as first-order factors. 
Results 
 Zero-Order Correlations. I first examined the zero-order correlations among all the 
variables in the current study. As can be seen in Table 1, the variables within a certain 
psychopathology were all strongly correlated with each other (e.g., measures of positive 
schizotypy with other measures of positive schizotypy). All psychopathology measures were 
significantly associated with all other psychopathology measures with the exception of the Mood 
Disorder Questionnaire (hypomania) with the Social Anhedonia scale (negative schizotypy), 
which was nonsignificant.  
Structural Model of Psychopathology. The primary goal of the current research was to 
determine where hypomania fits into a structural model of psychopathology. As can be seen in 
Table 2, Model 1 (in which all forms of psychopathology were independent, without the 
presence of higher order factors), Model 4 (in which hypomania was considered to be a part of 
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the positive schizotypy and depression simultaneously), and Model 7 (in which OCD and 
hypomania crossloaded onto both a thought disorder and an internalizing higher-order factor fit 
the data well according to the absolute fit indices). Model 7 was retained as the best fitting model 
for three reasons. First, it had the lowest BIC, which was my primary indicator of the best fitting 
model (Vrieze, 2012). Second, Model 7 was the most parsimonious of the three well-fitting 
models because it required the estimation of only 90 parameters rather than 103 and 100 
parameters for Model 1 and Model 4, respectively. Third, Model 7 (Figure 1) is the most 
consistent with previous research, which has nearly universally found the existence of higher-
order internalizing and thought disorder factors. A complete list of coefficients and associations 
for Model 7 can be seen in Tables 3-5. 
 Personality Variables on Psychopathology. A series of regressions was conducted in 
which each of the five personality variables were regressed on each of the seven first-order 
factors. A summary of results can be seen in Table 6, with a visual representation in Figure 2. 
After using a Bonferroni correction for multiple comparisons, significance was determined to be 
alpha ≤ .001. Negative schizotypy was negatively associated with extraversion, agreeableness, 
conscientiousness, and openness and positively associated with neuroticism. Positive schizotypy 
was negatively associated with agreeableness and conscientiousness, and positively associated 
with neuroticism. Hypomania was negatively associated with extraversion and 
conscientiousness, and positively associated with neuroticism. OCD was negatively associated 
with extraversion, agreeableness, and conscientiousness, and positively associated with 
neuroticism. Depression was negatively associated with extraversion and conscientiousness, and 
positively associated with neuroticism. Anxiety was negatively associated with extraversion and 
conscientiousness, and positively associated with neuroticism. Finally, social anxiety was 
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negatively associated with extraversion, agreeableness, and conscientiousness, and positively 
associated with neuroticism. Note that conscientiousness was negatively associated with every 
psychopathology while neuroticism was positively associated with every psychopathology. 
Openness was only negatively associated with negative schizotypy. 
Discussion 
 Recent attempts to structurally model psychopathology have largely shown that 
psychopathologies tend to cluster into higher-order dimensions or spectra (Kotov et al., 2017). 
To date, the question regarding where hypomania fits into these dimensions is unanswered. Thus, 
the primary goal of the current research was to determine where hypomania fits within the 
structure of psychopathology. The best fitting model included a first-order hypomania factor that 
crossloaded both on the higher-order internalizing factor and the higher-order thought disorder 
factor. This result is consistent with previous research suggesting hypomania shares similarities 
with both depression and schizophrenia (Blanco et al., 2015; Caspi et al., 2014; Forbush & 
Watson, 2013; Keyes et al., 2013; Kotov et al., 2011; Kotov et al., 2015; Watson, 2005; Watson 
et al., 2012). Specifically, mood disturbances are central to both internalizing disorders and 
hypomania (Achenbach, 1966; American Psychiatric Association, 2013).  
Similarities between hypomania and thought disorder include increased grandiosity with 
frequent psychotic symptoms experienced by those in a manic/hypomanic state (Dunayevich & 
Keck, 2000; Goodwin & Jamison, 1990; Turkington & Kingdon, 1996; Verduox et al., 1998; 
Wigman et al., 2012). In addition, the overlap of mania with thought disorder and internalizing 
disorders is underscored by the DSM-5 diagnosis of schizoaffective disorder, which is essentially 
a combination of a psychotic-spectrum disorder and a mood disorder (American Psychiatric 
Association, 2013).  
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The OCD first-order factor also crossloaded on both the internalizing and thought 
disorder factors. This finding is consistent with some previous research that indicates the 
obsessions in OCD share similar qualities to delusions in schizophrenia-spectrum disorders, 
while also showing similarities to anxiety and other internalizing disorders (Chmielewski & 
Watson, 2008; Keyes et al., 2013; Krueger & Markon, 2006; Miller et al., 2008; Poyurovsky & 
Koran, 2005, Sobin et al., 2000).  
The current research found that subscales of common constructs factored together. This 
led to a well-fitting seven-factor structure of the data wherein positive schizotypy, negative 
schizotypy, hypomania, depression, anxiety, social anxiety, and obsessive-compulsive disorder 
were separate factors (i.e., Model 1). Models containing fewer factors did not fit the data as well. 
For example, Models 2-4 all tested hypomania scales as loading onto depression, positive 
schizotypy, or both; none of these models fit the data well. For this reason, the seven-factor 
model was retained and then used to test the higher-order structure of the data. Overall, this 
suggests that these seven constructs (i.e., positive schizotypy, negative schizotypy, hypomania, 
OCD, anxiety, depression, and social anxiety) can be discriminated from each other. This finding 
is especially important for the interpretation of hypomania, and suggests that it is distinct from 
both positive schizotypy and internalizing pathology, which is consistent with previous research. 
As mentioned, the best fitting model included the first-order hypomania factor cross loading on 
both the thought disorder and internalizing second-order factors. This finding is consistent with 
previous postulations that hypomania is associated with both positive schizotypy (Caspi et al., 
2014; Keyes et al., 2013; Kotov et al., 2011) and depression (Blanco et al., 2015; Forbush & 
Watson, 2013; Keyes et al., 2013; Kotov et al., 2015; Watson, 2005; Watson et al., 2012). This 
finding is consistent with the HiTOP model, which provisionally had hypomania crossloading on 
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both the thought disorder and internalizing spectra (Kotov et al., 2017). Like the HiTOP model, 
this finding partially supports the Kraepelinian dichotomy. On the subclinical level, positive 
schizotypy and hypomania appear to be highly related and part of the same spectrum that likely 
functions through similar processes. Yet at the same time, hypomania’s crossloading on 
depression indicates that the mood component can separate the two and show differential 
relations with other psychopathology. 
As previously mentioned, the connection between bipolar disorders and schizophrenia 
spectrum disorders has been widely examined since Kraepelin proposed the dichotomy 
(Kraepelin, 1896). This dichotomy has been questioned throughout the years (Lake & Hurwitz, 
2007), but has been maintained through the current diagnostic system (American Psychiatric 
Association, 2013). Research in behavioral genetics (Berrettini, 2003; Cardno & Owen 2014; 
Craddock, O’Donovan, & Owen 2005; Schulze et al., 2014), phenomenology (Boks, Leask, 
Vermunt, & Kahn, 2007; Murray et al., 2004; Owens & Johnstone, 2006), and risk factors and 
development (e.g., Hallahan et al., 2011; Lewinsohn, Seeley, Roberts, & Allen, 1997; Sham, 
MacLean, & Kendler, 1994; Laursen, Munk-Olsen, Nordentoft, & Mortensen, 2007) has also 
pointed to the possibility that the two disorders are highly related, if not part of the same 
spectrum. At the same time, research in those areas has suggested that they are in fact distinct 
(Cannon et al., 2002; Chen et al., 2013; Leucht, Helfer, Dold, Kissling, & McGrath, 2015; Lim et 
al., 2014; Qureshi & Frangou, 2002). The current research supports a perspective indicating 
overlapping symptomatology, with clear distinctions. Hypomania was tested as solely belonging 
to the thought disorder spectrum or as part of positive schizotypy as a first-order factor. In both 
of these scenarios, the model did not fit the data as well, indicating that hypomania (and 
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presumably mania) cannot be considered synonymous with positive schizotypy (or positive 
symptoms in schizophrenia). 
In addition to being highly related to, but distinct from, positive schizotypy, hypomania 
has the same relation to depression. As mentioned, depressive symptoms are a core feature of 
bipolar disorders in traditional nosologies (American Psychiatric Association, 2013). The two 
share similar developmental characteristics (Betts, Williams, Najman, & Alati, 2016; Payá et al., 
2013; Zammit et al., 2004) and are considered to have reciprocal cycling between the two types 
of symptoms in bipolar disorders (American Psychiatric Association, 2013). However, there are 
several reasons that hypomania and depression are distinct constructs. First, by definition, they 
involve experiences that exist on opposite sides of the affect spectrum. Second, they appear to 
have different biological mechanisms, represented by their differential response to 
psychopharmacological treatments (Stahl & Grady, 2014). The current results indicate that 
hypomania and depression are in fact related, as is currently reflected in the DSM-5. Models in 
which hypomania was either not related to depression or solely related to depression did not fit 
the data well. Similar to the relation between positive schizotypy and hypomania, depression and 
hypomania seem to be distinct, but highly related, constructs.  
 In addition to hypomania loading on both the thought disorder and internalizing spectra, 
the best fitting model included OCD on both spectra. This finding was somewhat surprising 
because most recent structural models have suggested that OCD either loads along with 
internalizing or forms a distinct factor (e.g., Kotov et al., 2011; Kotov et al., 2017; Wright et al., 
2012) though others have mentioned that it might be partially related to thought disorder (Caspi 
et al., 2014; Watson, Wu, & Cutshall, 2004).  
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Perhaps the best reflection of OCD’s changing position within the larger framework of 
psychopathology can be seen through how it has changed in the DSM. In the DSM-IV, OCD was 
considered to be part of anxiety disorders (American Psychiatric Association, 2000), which had 
clearly been determined to be part of the internalizing spectrum. In this sense, OCD has 
traditionally been viewed as an internalizing disorder. By the release of the DSM-5, OCD’s 
position had changed and currently exists as its own section that is considered distinct from 
anxiety (American Psychiatric Association, 2013). This represents the changing perspective of 
OCD, and allows for the possibility that its placement along with anxiety disorders is inaccurate. 
Results of the current study indicate that it may in fact be connected to anxiety and other 
internalizing psychopathology while also being related to the psychotic disorders spectrum.  
Though OCD has been shown in the past to load solely onto the internalizing spectrum, 
these data support the notion that OCD symptoms (or at least the obsessive portions) are also 
closely related to thought disorder symptoms such as odd thinking, a primary component seen in 
positive schizotypy. One potential explanation for the difference between the current results and 
the previous findings is that previous structural attempts have used full-blown psychosis instead 
of subclinical psychotic processes. OCD symptoms may be closely related to subclinical thought 
disorder but differ from thought disorder symptoms seen in those who have converted to a 
schizophrenia spectrum disorder. 
 There are marked similarities between unusual beliefs experienced with positive 
schizotypy and the obsessions that are essential for a diagnosis of OCD. For instance, both 
require unrealistic perceptions of cause and effect. In fact, the obsessions seen in OCD could 
sometimes be considered unusual beliefs (e.g., contamination beliefs with health outcomes that 
are highly unlikely). However, delusions are deeply-held beliefs that are maintained when clear 
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contradictory evidence is presented. Obsessions, on the other hand, are recognized by the 
individual as not rational, but are nevertheless very compelling. To treat both, replacement 
beliefs are usually utilized (Clark & Beck, 2010; Nelson, 2005), though exposure is typical used 
for obsessions (Abramowitz et al., 2011; Foa, Deacon, & Whiteside, 2005). To the best of my 
knowledge, there is no evidence of treatment efficacy for exposure in delusions.  
One possibility for the similarity between obsessions and delusions is thought-action 
fusion. Thought-action fusion is the belief that simply thinking about an action is identical to 
actually completing that action, and is common in people with OCD (Berle & Starcevic, 2005; 
Rachman, 1993; Salkovskis, 1985; Shafran, Thordarson, & Rachman, 1996). In fact, some 
notions of OCD posit that thought-action fusion is a driving mechanism in maintaining the 
symptoms associated with the disorder. Thought-action fusion has also recently been studied in 
people with schizophrenia, with results indicating that people with schizophrenia endorse 
thought-action fusion likelihood to a greater extent that comparison participants, and thoughts 
associated with unethical behaviors were associated with delusional beliefs (Berle, Blaszczynski, 
Einstein, & Menzies, 2006). Given its delusion-like presentation, individuals high on measures 
of positive schizotypy may also experience this phenomenon, but potentially to a lesser extent. It 
is important to note, however, that in the previously-mentioned study, there were still low levels 
of endorsement overall for thought-action fusion beliefs in the chronic schizophrenia sample. 
This may indicate that thought-action fusion is one of multiple different shared mechanisms for 
the overlap between schizophrenia-spectrum disorders and OCD. Specific measures of thought-
action fusion were not included in this study, however, future studies may examine to what 
extent this phenomenon is driving this association. 
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Despite the finding that OCD crossloaded on the thought disorder spectrum and the 
phenomenological similarities, there are several important distinctions between the disorders. 
First, the current study indicates that OCD also crossloads with internalizing psychopathology. 
This is consistent with previous research findings demonstrating that OCD loads on the 
internalizing spectrum in structural analyses. Second, though obsessions and delusions are 
similar as mentioned previously, there are notable differences. Third, even with potentially 
overlapping symptoms, there are clear distinctions. For instance, the experience of hallucinations 
within psychotic disorders is frequently a key diagnostic feature but is not present in typical 
OCD (American Psychiatric Association, 2013). Fourth, there are important differences in 
functioning and quality of life or morbidity in people with schizophrenia compared to people 
with schizophrenia and comorbid OCD symptoms. People in the latter group are usually lower 
functioning, have more hospitalizations, and more psychosocial difficulties (Berman et al., 1998; 
Niendam, Berzak, Cannon, & Bearden, 2009; Poyurovsky et al., 2001; Samuel et al., 1993). 
Comparing individuals with each disorder independently shows that those with schizophrenia 
experience a lower quality of life compared to those with OCD (Koran, Thienemann, & 
Davenport, 1996; Spitzer et al., 1995). One reason schizophrenia-spectrum disorders are 
associated with higher morbidity and lower quality of life than are OCD-related disorders is that 
people with schizophrenia often also have negative symptoms and cognitive deficits that seem to 
drive the lowered quality of life in people. Finally, a first-order model in which the OCD 
indicators loaded along with positive schizotypy did not fit the data well and fit worse than a 
model with OCD and positive schizotypy loading on separate factors. Thus, it appears that OCD 
can clearly be discriminated from psychotic disorders. Future research may further explicate 
these distinctions using general population and clinical samples. 
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 In addition to the findings related to OCD, another important finding of the current 
research is the replication of findings supporting an internalizing spectrum. As is supported 
widely in the literature, depression, anxiety, and social anxiety loaded onto a second-higher 
internalizing factor (Achenbach, 1966; Achenbach et al., 1991; Blanco et al., 2015; Lahey et al., 
2004; Kotov et al., 2017). The current study adds to cross-cultural literature by replicating these 
findings in an ethnically diverse sample, suggesting that this structure could hold up across 
ethnicities (Krueger et al., 2003).  
 Interestingly, negative schizotypy did not load onto a higher-order factor. Its indicators, 
though generally considered to be part of a broader schizotypy construct (Kwapil & Barrantes-
Vidal, 2015), also did not combine to create a total schizotypy first-order factor. The 
differentiation between negative schizotypy and positive schizotypy is well-documented 
(Chmielewski & Watson, 2008; Kwapil & Barrantes-Vidal, 2015; Raine et al., 1994; Tandon, 
Nasrallah & Keshavan, 2009), however, given that they both are associated with an increased 
risk of schizophrenia, the continued support indicating that they also belong to different higher-
order factors is important. In the HiTOP model, negative schizotypy is not directly mentioned, 
but schizoid personality disorder is part of separate higher-order spectrum referred to as 
detachment, though it crossloads onto the thought disorder spectrum (Kotov et al., 2017). At the 
same time, the individual symptoms making up negative schizotypy are all included on the 
detachment spectrum. The current study did not directly measure other forms of detachment. 
Future research could include multiple measures of negative schizotypy along with multiple 
measures of detachment to determine whether negative schizotypy loads along with detachment 
or forms a distinct factor.   
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 Regarding the analyses involving personality measures, the current results are consistent 
with some previous studies, but inconsistent with others. For example, researchers have long 
debated whether openness to experience is relevant to psychopathology, with some researchers 
suggesting that it should be associated with increased positive schizotypy (Ross, Lutz, & Bailley, 
2004; Edmundson, Lynam, Miller, Gore, & Widiger, 2011). In the current research, openness to 
experience was only, and negatively, associated with negative schizotypy. In recent 
conceptualizations of personality pathology such as the Personality Inventory for the DSM-5, 
openness is excluded entirely (American Psychiatric Association, 2013). In these models, 
maladaptive openness is replaced by psychoticism, which is often used interchangeably with 
positive schizotypy. The lack of significant findings for relations with openness provides more 
support for removing openness from personality pathology conceptualizations.   
A second finding related to personality was that neuroticism and conscientiousness are 
both associated with all seven first-order factors. This could represent an increased liability based 
on these traits, or reflect common resulting behaviors from the difficulty of suffering from a 
mental illness. Other than neuroticism and conscientiousness, the other factors from the five-
factor personality model showed differential relations across psychopathologies. As anticipated, 
neuroticism was most strongly associated with internalizing psychopathology, specifically 
anxiety. In line with past research, extraversion was strongly associated with both negative 
schizotypy and social anxiety (Krueger & Markon, 2014). Negative schizotypy encompasses 
social anhedonia, which is distinct but related to social anxiety (Brown, Silvia, Myin-Germeys, 
Lewandowski, & Kwapil, 2008). Though they differ, the behavioral result of both may be similar 
in that they lead one to avoid social situations, in other words, being less extroverted. 
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Importantly, however, social anxiety is generally considered to be internalizing pathology, while 
social anhedonia would be related to social withdrawal and detachment (Kotov et al., 2017).  
 As with all studies, this study had limitations that may need to be addressed in future 
studies. The first is that this study examined only two spectra: internalizing and thought disorder. 
Some evidence suggests that hypomania may in fact be associated with externalizing pathology 
as well such as attention deficit hyperactivity disorder (ADHD; see Brody, 2001 for a review). 
Hypomania may be related to ADHD, and externalizing pathology more generally, in a multitude 
of ways. First, increased activity is arguably the defining feature of both ADHD, hyperactive 
type, and (hypo)mania (Biederman et al., 1998; Geller et al., 1998). Second, both disorders are 
also associated with increased impulsivity (Barkley, 1997; Brody, 2001). Despite clear 
knowledge that they are separate disorders with different pathophysiological and neurological 
differences (Blumberg et al., 2003; Dickstein et al., 2005; Pliszka et al., 2000), there exists 
enough overlap to reason that they could both be part of externalizing pathology. 
The distinction between ADHD and the bipolar disorders is important because people 
with ADHD, particularly children, are often misdiagnosed as bipolar disorder and vice versa 
(Biederman et al., 1998; Carlson, 1998; Geller et al., 1998). Given the differences in appropriate 
treatment, differential diagnosis at early stages is essential. In addition to ADHD, hypomania 
may be related to other types of externalizing pathology such as oppositional defiant disorder 
(ODD) and intermittent explosive disorder (IED). Both of these disorders have components that 
mirror those seen in people with mania or hypomania, such as those mentioned above. Future 
research could also include measures of externalizing pathology to see if hypomania loads along 
with those symptoms or crossloads with them in addition to internalizing and/or thought 
disorder.  
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 A second limitation of this study was the use of undergraduate students, who may differ 
from a clinical population. Since the HiTOP model examines traits and symptoms at multiple 
levels, one would assume that subclinical representations of psychopathology would be 
structured similarly to clinical presentations. Although psychosis is currently conceptualized as a 
spectrum, with varying levels that can be modeled in general samples (van Os, Linscott, Myin-
Germeys, Delespaul, & Krabbendam, 2009; Yung et al., 2009), undergraduates may not be 
representative of the general population. Undergraduate students likely have higher SES and 
higher IQs than a community sample, though research shows that undergraduates show levels of 
psychopathology that are comparable to those in the same age-range that are not attending 
college (Blanco et al., 2008). Future research could examine where hypomania fits in with the 
broader structure of psychopathology in clinical samples or samples drawn from the general 
population. 
 Another limitation of the current study is the use of self-report questionnaires as opposed 
to more intensive interviews. Though these particular self-report measures have shown strong 
reliability and validity in other studies (e.g., Akiskal et al., 2005; Chapman, Edell, & Chapman, 
1980; Lovibond & Lovibond, 1993), the presence of multiple sources of information would 
inevitably increase the confidence with which results are interpreted. This would also allow for 
comparisons between self-perceptions of severity versus clinical opinions, potentially helping to 
merge subclinical and clinical models. 
Finally, an aspect of this study that is both a limitation and a strength was the presence of 
many measures regarding psychopathology administered at one time. Since the study was 
unproctored, it is possible that infrequent or inattentive responding may have influenced the 
results. To mitigate this risk, the infrequency subscale of the Wisconsin Schizotypy Scales was 
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included to assess for careless or invalid responding. Using a cutoff of five (where higher 
indicates infrequent responding), we excluded 155 participants suspected of invalid responding, 
leading to our final sample size. Though this is roughly 14% of the total sample, we were still 
able to maintain sufficient power and have more confidence in the interpretation of results. 
Despite this attempt, it is still impossible to know for sure if the validity of answers was 
consistent across the study. 
The use of many measures can also be viewed as strength. In any structural equation 
modeling, the use of multiple observed variables to determine a latent variable is preferred over a 
single indicator—if the indicators are considered good measures—and usually contributes to 
more valid conclusions by reducing measurement error (Hayduk & Littvay, 2012). By using 
multiple indicators, we can be confident that results are not representative of a singular scale that 
is more subject to bias, but rather represents the psychopathology itself. This is also important in 
understanding relations between psychopathologies. For instance, to examine whether anxiety 
and depression belong to the same higher-order factor, using only the DASS (which has a 
subscale of each) would likely yield a stronger association than using multiple measures from 
different sources converging on each construct independently. Thus, the correlation between the 
scale scores could be related to method covariance rather than a true covariance between the 
constructs. 
A second strength is the measuring of symptoms instead of diagnoses. A large body of 
research is conducted in this way (e.g., Achenbach, 1966; Clark & Watson, 1991), and many of 
the aforementioned structural papers used this approach. This is important for two reasons. First, 
diagnoses have been shown to be less reliable than symptom scores, which is likely related to the 
fact that diagnoses are dichotomous (Chmielewski, Clark, Bagby, & Watson, 2015; Markon, 
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Chmielewski, & Miller, 2011; Regier et al., 2013). The second reason is that the current structure 
used to diagnose is possibly flawed in itself. In fact, the changing of this system is a major goal 
of HiTOP and other related efforts. Since the argument made in many of these studies is that the 
DSM is insufficient to accurately capture the true nature of mental illness, using diagnoses as 
defined by the DSM would be counterproductive. Moreover, many disorders are 
multidimensional with symptoms that overlap across disorders. A study that uses symptoms 
instead of diagnoses would allow for symptoms to load onto different factors, independent of the 
spectrum onto which their associated disorder loads. 
Finally, and related to the previous points, a third strength is that the measures in the 
current study examined symptoms of mental illness at differing levels of severity. By capturing 
clinical and subclinical dysfunction, results can be interpreted as representing a wider range of 
potential problems. In this sense, the models retained could be applied to multiple contexts, 
though more research should be conducted to ensure that associations are the same across 
severity of psychopathology.  
This research advances our understanding of psychopathology in two key ways. First, it 
adds further clarification to the Kraepelinian dichotomy, supporting the assertion that hypomania 
and positive schizotypy (and more broadly bipolar disorder and schizophrenia) are distinct but 
highly related constructs. This is important for two reasons including its clinical utility and 
empirical advancement. Clinically, the understanding that the two constructs are distinct, despite 
sometimes presenting nearly identically, can help guide decision-making. Regarding empirical 
advancement, that hypomania loads onto the thought disorder spectrum with positive schizotypy 
and the internalizing spectrum with depression indicates that it should be considered in future 
examinations of each of these two forms of psychopathology. 
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Second, these results further support the emerging perspective that OCD and 
schizophrenia-spectrum disorders are related. Obsessions and delusions, though notably 
different, may have similar pathways of development and maintenance. This should help inform 
future biological, psychological, and behavioral research by providing a baseline framework 
suggesting that the association is likely meaningful and that continued research is needed. 
 The results of this study are far from the final goal of comprehensively understanding 
and modeling mental illness. Some important areas of continued research that are needed include 
more work identifying common and differential biomarkers of different forms of 
psychopathology, understanding genetic susceptibilities that may be shared or different across 
psychopathologies, examining how other experiences such as ecological factors contribute to the 
development of different forms of mental illness, and using increasingly complex statistical 
analyses to determine the empirical relations between diagnoses and symptoms. Examples of 
statistical analyses that could be utilized to answer these issues include network analyses—where 
different forms of psychopathology can be seen as more closely linked to certain other forms—or 
growth modeling, whereby we may be able to determine if signs of one psychopathology early 
on are predictive of a course that enables the eventual development of another. For instance, 
unusual beliefs that are not of full clinical concern in adolescence may be indicative of an 
increased susceptibility to develop obsessions leading to a diagnosis of OCD. In addition to the 
areas above, expanding the methodology of the current study to include more measures from 
different spectra, as well as testing if a subclinical model can be integrated into a clinical model, 
should be primary goals of future research. 
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Conclusion 
The primary goal of the current research was to examine whether hypomania is better 
conceptualized as part of the internalizing spectrum, the thought disorder spectrum, or a 
combination of both. These results suggest that hypomania loads on both spectra, which is 
consistent with the provisional structure of the recently-developed HiTOP model. In addition, the 
results of the current research suggest that OCD symptoms also crossload on the thought disorder 
and internalizing spectra. The differential relations between personality traits and different types 
of psychopathology also help to understand the relations among psychopathology and “normal” 
personality traits.  
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Table 1. Bivariate correlations for all the scales used in the current study 
 
1 2 3 4 5 6 7 8 9 10 11 12 
Positive Schizotypy Measures             
   1) PerAb 1            
   2) MagicId .686** 1           
   3) SPQ-MI .481** .650** 1          
   4) SPQ-UPE .615** .647** .679** 1         
Negative Schizotypy Measures             
   5) SPQ-NCF .339** .282** .384** .494** 1        
   6) SPQ-CA .394** .301** .365** .521** .766** 1       
   7) SocAn .438** .334** .250** .308** .580**
* 
.471** 1      
Hypomania Measures             
   8) HPS .314** .379** .336** .403** .245** .254** .093* 1     
   9) MDQ .207** .288** .259** .316** .153** .190** .071 .348** 1    
   10) TEMPS-Cyc -.381** -.401** -.361** -.507** -.476** -.469** -.305** -.461** -.395** 1   
OCD Measures             
   11) VOCI -.539** -.451** -.428** -.529** -.421** -.480** -.313** -.398** -.237** .487** 1  
   12) OCI-R .487** .411** .332** .432** .367** .374** .344** .246** .247** -.432** -.607** 1 
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Table 1. (Continued) Bivariate correlations for all the scales used in the current study 
  
1 2 3 4 5 6 7 8 9 10 11 12 
Depression Measures             
   13) IDAS-Dep .332** .262** .243** .343** .417** .422** .336** .213** .248** -.490** -.436** .507** 
    14) DASS-Dep .345** .271** .250** .291** .344** .375** .294** .180** .281** -.405** -.418** .445** 
   15) CES-D .312** .272** .260** .349** .353** .370** .272** .221** .338** -.454** -.411** .426** 
   16) PHQ .336** .273** .280** .389** .442** .454** .344** .247** .271** -.537** -.438** .504** 
   17) PROMIS-B .286** .228** .210** .317** .437** .445** .324** .139** .191** -.471** -.382** .434** 
Anxiety Measures             
   18) DASS-Anx .378** .351** .315** .338** .274** .309** .256** .253** .322** -.377** -.443** .491** 
   19) PSWQ .112** .120** .114** .218** .323** .312** .168** .196** .165** -.341** -.378** .352** 
   20) PROMIS-A .328** .263** .252** .364** .400** .424** .280** .229** .243** -.484** -.453** .508** 
Social Anxiety Measures             
   21) SPQ-ESA .196** .203** .314** .427** .643** .618** .212** .226** .165** -.440** -.412** .319** 
   22) IDAS-Soc .312** .265** .242** .355** .420** .450** .316** .197** .253** -.410** -.423** .510** 
Personality Measures             
   23) Extraversion -.107** -.017 -.009 -.111** -.542** -.522** -.383** .074* .038 .188** .215** -.189** 
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Table 1. (Continued) Bivariate correlations for all the scales used in the current study 
 
 
1 2 3 4 5 6 7 8 9 10 11 12 
   24) Agreeableness -.243** -.141** -.015 -.032 -.211** -.189** -.500** .073* .051 .050 .116** -.191** 
   25) Conscientiousness -.231** -.152** -.066* -.101* -.112** -.170** -.163** -.030 -.113** .184** .092* -.125** 
   26) Neuroticism .196** .172** .155** .241** -318** -311** .213** .199** .177** -.428** -.395** .365** 
   27) Openness -.098* -.017 .101* .083* -.149** -.147** -.227** .183** .150** .009 .080* -.105** 
 
 
13 14 15 16 17 18 19 20 21 22 23 24 
Depression Measures             
   13) IDAS-Dep 1            
   14) DASS-Dep .590** 1           
   15) CES-D .673** .703** 1          
   16) PHQ .780** .578** .694** 1         
   17) PROMIS-B .740** .572** .648** .743** 1        
Anxiety Measures             
   18) DASS-Anx .492** .808** .637** .478** .392** 1       
   19) PSWQ .512** .300** .338** .477** .453** .285** 1      
   20) PROMIS-A .722** .513** .590** .669** .701** .468** .596** 1     
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Table 1. (Continued) Bivariate correlations for all the scales used in the current study 
 
 
13 14 15 16 17 18 19 20 21 22 23 24 
Social Anxiety Measures             
   21) SPQ-ESA .378** .306** .319** .401** .393** .237** .464** .446** 1    
   22) IDAS-Soc .698** .479** .481** .606** .551** .452** .405** .595** .462** 1   
Personality Measures             
   23) Extraversion -.299** -.234** -.192** -.288** -.330** -.157** -.354** -.305** -.546** -.409** 1  
   24) Agreeableness -.104** -.115** -.014 -.050 -.087* -.093* .032 -.039 .011 -.110** .342** 1 
   25) Conscientiousness -.248** -.269** -.205** -.230** -.249** -.182** .043 -.142** -.068* -.232** .238** .356** 
   26) Neuroticism .517** .363** .384** -502** .488** .295** .585** .542** .370** .417** -.356** -.106** 
   27) Openness -.057 -.061 .057 .010 -.068* -.022 -.052 -.013 -.100* -.083* .438** .567** 
 
 25 26 27          
   25) Conscientiousness 1            
   26) Neuroticism -.202** 1           
   27) Openness .350** -.097* 1          
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Table 2. Model fit statistics 
Model Parameters AIC BIC SABIC χ2 df RMSEA Low High CFI TLI SRMR 
1 103 111642.056 112142.163 111815.040 1060.845 172 0.074 0.07 0.078 0.93 0.906 0.051 
2 97 111863.147 112334.122 112026.055 1293.936 178 0.081 0.077 0.085 0.913 0.886 0.064 
3 97 112007.121 112478.096 112170.029 1437.910 178 0.086 0.082 0.091 0.901 0.872 0.072 
4 100 111705.335 112190.875 111873.281 1130.123 175 0.076 0.072 0.080 0.925 0.901 0.050 
5* 90 112165.866 112602.852 112317.017 1610.654 185 0.090 0.086 0.094 0.888 0.860 0.068 
6* 89 112191.023 112623.155 112340.495 1637.812 186 0.091 0.087 0.095 0.886 0.859 0.070 
7 93 111688.227 112139.780 111844.417 1127.016 182 0.074 0.070 0.078 0.926 0.906 0.052 
8 92 111770.030 112216.727 111924.540 1210.819 183 0.077 0.073 0.081 0.919 0.898 0.060 
9* 89 112167.417 112599.548 112316.889 1614.206 186 0.090 0.086 0.094 0.888 0.861 0.069 
10* 88 112248.764 112676.040 112396.556 1697.552 187 0.092 0.088 0.096 0.882 0.854 0.072 
11* 88 112248.764 112676.040 112396.556 1697.552 187 0.092 0.088 0.096 0.882 0.854 0.072 
12* 92 112028.879 112475.577 112183.389 1469.668 183 0.086 0.082 0.090 0.899 0.873 0.060 
13* 90 112165.866 112602.852 112317.017 1610.654 185 0.090 0.086 0.094 0.888 0.860 0.068 
Model 1: A seven-factor model with positive schizotypy, negative schizoytypy, hypomania, depression, anxiety, social anxiety, and OCD loading on separate 
factors. Model 2: A six-factor model with hypomania scales and positive schizotypy scales loading onto the same factor. Model 3: A six-factor model with 
hypomania scales and depression scales loading onto the same factor. Model 4: A six-factor model with hypomania scales loading onto both the positive 
schizotypy scale and the depression scale. Model 5: A seven-factor model with two higher-order factors, thought disorder (positive schizotypy and 
hypomania) and internalizing (depression, anxiety, social anxiety, OCD, and hypomania). Model 6: A seven-factor model with two higher-order factors, 
thought disorder (positive schizotypy, negative schizotypy, and hypomania) and internalizing (depression, anxiety, social anxiety, OCD, and hypomania). 
Model 7: A seven-factor model with two higher-order factors, thought disorder (positive schizotypy, hypomania, and OCD) and internalizing (depression, 
anxiety, social anxiety, OCD, and hypomania). Model 8: A seven-factor model with two higher-order factors, thought disorder (positive schizotypy, negative 
schizotypy, hypomania, and OCD) and internalizing (depression, anxiety, social anxiety, OCD, and hypomania). Model 9: A seven-factor model with two 
higher-order factors, thought disorder (positive schizotypy and hypomania) and internalizing (depression, anxiety, social anxiety, and OCD). Model 10: A 
seven-factor model with one higher-order factor, internalizing (depression, anxiety, social anxiety, OCD, and hypomania). Model 11: A seven-factor model 
with two higher-order factors, thought disorder (positive schizotypy and negative schizotypy) and internalizing (depression, anxiety, social anxiety, OCD, and 
hypomania). Model 12: A seven-factor model with two higher-order factors, thought disorder (positive schizotypy and OCD) and internalizing (depression, 
anxiety, social anxiety, and OCD). Model 13: A seven-factor model with one higher-order factor, internalizing (depression, anxiety, and social anxiety). 
 
*Models would not converge without freeing residual error correlations between SPQ-NCF and SPQ-CA with SPQ-ESA  
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Table 3. Standardized estimates and standard errors for Model 7 
 Positive 
Schizotypy 
Negative 
Schizotypy 
Hypomania Depression Anxiety 
Social 
Anxiety 
OCD 
PerAb .753 (.022)       
MagicID .803 (.019)       
SPQ-UPE .821 (.019)       
SPQ-MI .724 (.023)       
SPQ-CA  .798 (.030)      
SPQ-NCF  .873 (.027)      
SocAn  .644 (.027)      
HPS   .566 (.028)     
TEMPS-Cyc   .825 (.022)     
MDQ   .507 (.029)     
CESDR    .808 (.014)    
DASS-Dep    .715 (.018)    
IDAS-Dep    .877 (.010)    
PHQ    .875 (.010)    
PROMIS-B    .835 (.012)    
DASS-Anx     .633 (.023)   
PROMIS-A     .851 (.014)   
PSWQ     .640 (.023)   
SPQ-ESA      .580 (.027)  
IDAS-Soc      .781 (.021)  
OCIR       .772 (.019) 
VOCI       .791 (.019) 
All values are significant at p < .001 
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Table 4. First-order factor loading estimates and standard errors for higher-order factors for 
Model 7 
 Thought Disorder Internalizing 
Positive Schizotypy .958 (.041)  
Hypomania .470 (.051) .459 (.048) 
OCD .500 (.050) .514 (.048) 
Depression  .927 (.009) 
Anxiety  .972 (.011) 
Social Anxiety  .924 (.019) 
Negative Schizotypy   
All values are significant at p < .001 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5. Higher-order factor relations to each other and negative schizotypy (estimates and 
standard errors) 
 Thought Disorder Internalizing 
Internalizing .524 (.039)  
Negative Schizotypy .533 (.037) .628 (.028) 
All values are significant at p < .001 
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Table 6. Personality variable regressions on each psychopathology 
 Positive Schizotypy Negative Schizotypy Hypomania Depression Anxiety Social Anxiety OCD 
Extraversion -.081 (.039)* -.571 (.029)*** -.284 (.041)*** -.394 (.031)*** -.410 (.032)*** -.564 (.031)*** -.383 (.036)*** 
Agreeableness -.134 (.038)*** -.367 (.035)*** -.096 (.040)* -.109 (.036)** -.086 (.038)* -.153 (.039)*** -.164 (.038)*** 
Conscientiousness -.187 (.037)*** -.249 (.036)*** -.247 (.037)*** -.273 (.034)*** -.213 (.036)*** -.246 (.037)*** -.215 (.036)*** 
Neuroticism .313 (.035)*** .445 (.034)*** .581 (.029)*** .609 (.023)*** .662 (.022)*** .646 (.025)*** .580 (.027)*** 
Openness .023 (.038) -.206 (.037)*** .008 (.040) -.060 (.037) -.054 (.038) -.124 (.039)** -.074 (.038) 
Estimate (Standard Error) * p < .05, ** p < .01, *** p < .001 
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Figure 1. Model 7 structure 
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Figure 2. Personality variable regressions 
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